136 related articles for article (PubMed ID: 6098205)
1. Clinical evaluation of a temperature-sensitive bovine viral diarrhea vaccine strain.
Lobmann M; Charlier P; Florent G; Zygraich N
Am J Vet Res; 1984 Dec; 45(12):2498-503. PubMed ID: 6098205
[TBL] [Abstract][Full Text] [Related]
2. Safety of a temperature-sensitive vaccine strain of bovine viral diarrhea virus in pregnant cows.
Lobmann M; Charlier P; Klaassen CL; Zygraich N
Am J Vet Res; 1986 Mar; 47(3):557-60. PubMed ID: 3008601
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
Fairbanks K; Schnackel J; Chase CC
Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
[TBL] [Abstract][Full Text] [Related]
4. Response of cattle persistently infected with noncytopathic bovine viral diarrhea virus to vaccination for bovine viral diarrhea and to subsequent challenge exposure with cytopathic bovine viral diarrhea virus.
Bolin SR; McClurkin AW; Cutlip RC; Coria MF
Am J Vet Res; 1985 Dec; 46(12):2467-70. PubMed ID: 3002214
[TBL] [Abstract][Full Text] [Related]
5. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
6. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of a combined parapox/BVD vaccine.
Büttner M
Dev Biol Stand; 1986; 65():221-6. PubMed ID: 3030862
[TBL] [Abstract][Full Text] [Related]
8. Serologic detection and practical consequences of antigenic diversity among bovine viral diarrhea viruses in a vaccinated herd.
Bolin SR; Littledike ET; Ridpath JF
Am J Vet Res; 1991 Jul; 52(7):1033-7. PubMed ID: 1654030
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a bovine virus diarrhea vaccine.
Chapek ML; McClaughry LE; Wilkins LM
Mod Vet Pract; 1978 Oct; 59(10):755-7. PubMed ID: 216898
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pneumopathogenicity of two strains of bovine viral diarrhea virus.
Potgieter LN; McCracken MD; Hopkins FM; Guy JS
Am J Vet Res; 1985 Jan; 46(1):151-3. PubMed ID: 2982295
[TBL] [Abstract][Full Text] [Related]
11. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
[TBL] [Abstract][Full Text] [Related]
12. Viral and viral protein specificity of antibodies induced in cows persistently infected with noncytopathic bovine viral diarrhea virus after vaccination with cytopathic bovine viral diarrhea virus.
Bolin SR
Am J Vet Res; 1988 Jul; 49(7):1040-4. PubMed ID: 2844105
[TBL] [Abstract][Full Text] [Related]
13. Specificity of neutralizing and precipitating antibodies induced in healthy calves by monovalent modified-live bovine viral diarrhea virus vaccines.
Bolin SR; Ridpath JF
Am J Vet Res; 1989 Jun; 50(6):817-21. PubMed ID: 2548419
[TBL] [Abstract][Full Text] [Related]
14. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
Ellsworth MA; Fairbanks KK; Behan S; Jackson JA; Goodyear M; Oien NL; Meinert TR; Leyh RD
Vet Ther; 2006; 7(3):295-304. PubMed ID: 17039452
[TBL] [Abstract][Full Text] [Related]
15. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
[TBL] [Abstract][Full Text] [Related]
16. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
[TBL] [Abstract][Full Text] [Related]
17. A bovine virus diarrhea calfhood vaccination trial in a persistently infected herd: effects on titres, health and growth.
Ernst PB; Butler DG
Can J Comp Med; 1983 Apr; 47(2):118-23. PubMed ID: 6309345
[TBL] [Abstract][Full Text] [Related]
18. Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves.
Hamers C; Di Valentin E; Lecomte C; Lambot M; Joris E; Genicot B; Pastoret PP
Vet J; 2002 Jan; 163(1):61-7. PubMed ID: 11749137
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
[TBL] [Abstract][Full Text] [Related]
20. Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea.
Cortese VS; Whittaker R; Ellis J; Ridpath JF; Bolin SR
Am J Vet Res; 1998 Jul; 59(7):848-50. PubMed ID: 9659549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
